Changes to certain s100 programs

Page last updated: 1 October 2017

In 2015, changes were made to certain Section 100 (s100) programs under the PBS.  These changes, which included the introduction of community access arrangements for a number of medicines available under the Highly Specialised Drugs Program, were recommended by the Pharmaceutical Benefits Advisory Committee. Frequently Asked Questions that outline the changes have been developed to assist prescribers, suppliers and patients.